Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications
This report describes the approach the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) used to assess the strength of published evidence pertinent to individual NKF-DOQI Clinical Practice Guidelines, as well as the relationship between that approach and methods used by the...
Gespeichert in:
| Veröffentlicht in: | American journal of kidney diseases 2000-07, Vol.36 (1), p.1-11 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 11 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | American journal of kidney diseases |
| container_volume | 36 |
| creator | Steinberg, Earl P. Eknoyan, Garabed Levin, Nathan W. Eschbach, Joseph W. Golper, Thomas A. Owen, William F. Schwab, Steven |
| description | This report describes the approach the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) used to assess the strength of published evidence pertinent to individual NKF-DOQI Clinical Practice Guidelines, as well as the relationship between that approach and methods used by the US Preventive Services Task Force, the Cochrane Collaboration, and the Agency for Health Care Policy and Research to rate the quality and/or strength of evidence. We also present the results of an analysis of the strength of evidence underlying the NKF-DOQI Guidelines showing that one cannot infer the quality of evidence reported in a study (rated either on a 0-to-1 scale or categorically as excellent, very good, good, fair, or poor) simply by knowing the type of study design used (randomized trial, nonrandomized trial, natural experiment, cohort study, cross-sectional study, case-control study, case report). Issues related to assessment of the strength of evidence underlying a practice guideline opposed to that reported in an individual study are highlighted. |
| doi_str_mv | 10.1053/ajkd.2000.8233 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71224736</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638600701570</els_id><sourcerecordid>71224736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-e4523656e3f79574007a786b04ab9a826966351e87d8c15c20aff5a1ca17b3d23</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EotvClSPyAXFqFjtO7IQbKi0gClzgbHntSTsliVPbWSk_kP-F010BF06Wn795z5pHyAvOtpzV4o25--m2JWNs25RCPCIbXpeikI1oHpMNK1VZSNHIE3Ia412mWiHlU3LCWaOyLDfk1xdIt95FOkdwNHkKe9PPJgFNt0DvZ9NjWqjvso4ORgt0Hh2EfsHx5gH5ahL60fT0M7oRFnrlM_CgFQ5Nv0SM1M_J-gHiHz8cMWGG9kBtny82z0_B2IQ54GbOSVmF-Ja-h2gDTqvdOe1wdDk2nlMzOorD1OfB9Sk-I08600d4fjzPyI-ry-8XH4vrbx8-Xby7LqyQbSqgysuRtQTRqbZWFWPKqEbuWGV2rWlK2Uopag6Nco3ltS2Z6bracGu42glXijPy-uA7BX8_Q0x6wGih780Ifo5a8bKslJAZ3B5AG3yMATo9BRxMWDRnei1Or8XptTi9FpcHXh6d590A7h_80FQGXh0BE_O6umBGi_EvV9W1alesOWCQ17BHCDpaXHtzGMAm7Tz-7wu_AXgpuW4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71224736</pqid></control><display><type>article</type><title>Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Steinberg, Earl P. ; Eknoyan, Garabed ; Levin, Nathan W. ; Eschbach, Joseph W. ; Golper, Thomas A. ; Owen, William F. ; Schwab, Steven</creator><creatorcontrib>Steinberg, Earl P. ; Eknoyan, Garabed ; Levin, Nathan W. ; Eschbach, Joseph W. ; Golper, Thomas A. ; Owen, William F. ; Schwab, Steven</creatorcontrib><description>This report describes the approach the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) used to assess the strength of published evidence pertinent to individual NKF-DOQI Clinical Practice Guidelines, as well as the relationship between that approach and methods used by the US Preventive Services Task Force, the Cochrane Collaboration, and the Agency for Health Care Policy and Research to rate the quality and/or strength of evidence. We also present the results of an analysis of the strength of evidence underlying the NKF-DOQI Guidelines showing that one cannot infer the quality of evidence reported in a study (rated either on a 0-to-1 scale or categorically as excellent, very good, good, fair, or poor) simply by knowing the type of study design used (randomized trial, nonrandomized trial, natural experiment, cohort study, cross-sectional study, case-control study, case report). Issues related to assessment of the strength of evidence underlying a practice guideline opposed to that reported in an individual study are highlighted.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/ajkd.2000.8233</identifier><identifier>PMID: 10873866</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>anemia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; dialysis ; Dialysis Outcomes Quality Initiative (DOQI) ; Emergency and intensive care: renal failure. Dialysis management ; Evidence-Based Medicine ; Foundations ; Guidelines ; Humans ; Intensive care medicine ; Kidney Failure, Chronic - therapy ; Medical sciences ; meta-analysis ; Meta-Analysis as Topic ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Outcome Assessment (Health Care) ; Peritoneal Dialysis ; Practice Guidelines as Topic ; Renal Dialysis ; Renal failure ; structured review ; United States ; vascular access</subject><ispartof>American journal of kidney diseases, 2000-07, Vol.36 (1), p.1-11</ispartof><rights>2000 National Kidney Foundation, Inc</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-e4523656e3f79574007a786b04ab9a826966351e87d8c15c20aff5a1ca17b3d23</citedby><cites>FETCH-LOGICAL-c369t-e4523656e3f79574007a786b04ab9a826966351e87d8c15c20aff5a1ca17b3d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/ajkd.2000.8233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27925,27926,45996</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1455796$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10873866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steinberg, Earl P.</creatorcontrib><creatorcontrib>Eknoyan, Garabed</creatorcontrib><creatorcontrib>Levin, Nathan W.</creatorcontrib><creatorcontrib>Eschbach, Joseph W.</creatorcontrib><creatorcontrib>Golper, Thomas A.</creatorcontrib><creatorcontrib>Owen, William F.</creatorcontrib><creatorcontrib>Schwab, Steven</creatorcontrib><title>Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>This report describes the approach the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) used to assess the strength of published evidence pertinent to individual NKF-DOQI Clinical Practice Guidelines, as well as the relationship between that approach and methods used by the US Preventive Services Task Force, the Cochrane Collaboration, and the Agency for Health Care Policy and Research to rate the quality and/or strength of evidence. We also present the results of an analysis of the strength of evidence underlying the NKF-DOQI Guidelines showing that one cannot infer the quality of evidence reported in a study (rated either on a 0-to-1 scale or categorically as excellent, very good, good, fair, or poor) simply by knowing the type of study design used (randomized trial, nonrandomized trial, natural experiment, cohort study, cross-sectional study, case-control study, case report). Issues related to assessment of the strength of evidence underlying a practice guideline opposed to that reported in an individual study are highlighted.</description><subject>anemia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>dialysis</subject><subject>Dialysis Outcomes Quality Initiative (DOQI)</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Evidence-Based Medicine</subject><subject>Foundations</subject><subject>Guidelines</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Medical sciences</subject><subject>meta-analysis</subject><subject>Meta-Analysis as Topic</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Outcome Assessment (Health Care)</subject><subject>Peritoneal Dialysis</subject><subject>Practice Guidelines as Topic</subject><subject>Renal Dialysis</subject><subject>Renal failure</subject><subject>structured review</subject><subject>United States</subject><subject>vascular access</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFv1DAQhS0EotvClSPyAXFqFjtO7IQbKi0gClzgbHntSTsliVPbWSk_kP-F010BF06Wn795z5pHyAvOtpzV4o25--m2JWNs25RCPCIbXpeikI1oHpMNK1VZSNHIE3Ia412mWiHlU3LCWaOyLDfk1xdIt95FOkdwNHkKe9PPJgFNt0DvZ9NjWqjvso4ORgt0Hh2EfsHx5gH5ahL60fT0M7oRFnrlM_CgFQ5Nv0SM1M_J-gHiHz8cMWGG9kBtny82z0_B2IQ54GbOSVmF-Ja-h2gDTqvdOe1wdDk2nlMzOorD1OfB9Sk-I08600d4fjzPyI-ry-8XH4vrbx8-Xby7LqyQbSqgysuRtQTRqbZWFWPKqEbuWGV2rWlK2Uopag6Nco3ltS2Z6bracGu42glXijPy-uA7BX8_Q0x6wGih780Ifo5a8bKslJAZ3B5AG3yMATo9BRxMWDRnei1Or8XptTi9FpcHXh6d590A7h_80FQGXh0BE_O6umBGi_EvV9W1alesOWCQ17BHCDpaXHtzGMAm7Tz-7wu_AXgpuW4</recordid><startdate>20000701</startdate><enddate>20000701</enddate><creator>Steinberg, Earl P.</creator><creator>Eknoyan, Garabed</creator><creator>Levin, Nathan W.</creator><creator>Eschbach, Joseph W.</creator><creator>Golper, Thomas A.</creator><creator>Owen, William F.</creator><creator>Schwab, Steven</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000701</creationdate><title>Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications</title><author>Steinberg, Earl P. ; Eknoyan, Garabed ; Levin, Nathan W. ; Eschbach, Joseph W. ; Golper, Thomas A. ; Owen, William F. ; Schwab, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-e4523656e3f79574007a786b04ab9a826966351e87d8c15c20aff5a1ca17b3d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>anemia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>dialysis</topic><topic>Dialysis Outcomes Quality Initiative (DOQI)</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Evidence-Based Medicine</topic><topic>Foundations</topic><topic>Guidelines</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Medical sciences</topic><topic>meta-analysis</topic><topic>Meta-Analysis as Topic</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Outcome Assessment (Health Care)</topic><topic>Peritoneal Dialysis</topic><topic>Practice Guidelines as Topic</topic><topic>Renal Dialysis</topic><topic>Renal failure</topic><topic>structured review</topic><topic>United States</topic><topic>vascular access</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steinberg, Earl P.</creatorcontrib><creatorcontrib>Eknoyan, Garabed</creatorcontrib><creatorcontrib>Levin, Nathan W.</creatorcontrib><creatorcontrib>Eschbach, Joseph W.</creatorcontrib><creatorcontrib>Golper, Thomas A.</creatorcontrib><creatorcontrib>Owen, William F.</creatorcontrib><creatorcontrib>Schwab, Steven</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steinberg, Earl P.</au><au>Eknoyan, Garabed</au><au>Levin, Nathan W.</au><au>Eschbach, Joseph W.</au><au>Golper, Thomas A.</au><au>Owen, William F.</au><au>Schwab, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2000-07-01</date><risdate>2000</risdate><volume>36</volume><issue>1</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>This report describes the approach the National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-DOQI) used to assess the strength of published evidence pertinent to individual NKF-DOQI Clinical Practice Guidelines, as well as the relationship between that approach and methods used by the US Preventive Services Task Force, the Cochrane Collaboration, and the Agency for Health Care Policy and Research to rate the quality and/or strength of evidence. We also present the results of an analysis of the strength of evidence underlying the NKF-DOQI Guidelines showing that one cannot infer the quality of evidence reported in a study (rated either on a 0-to-1 scale or categorically as excellent, very good, good, fair, or poor) simply by knowing the type of study design used (randomized trial, nonrandomized trial, natural experiment, cohort study, cross-sectional study, case-control study, case report). Issues related to assessment of the strength of evidence underlying a practice guideline opposed to that reported in an individual study are highlighted.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>10873866</pmid><doi>10.1053/ajkd.2000.8233</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-6386 |
| ispartof | American journal of kidney diseases, 2000-07, Vol.36 (1), p.1-11 |
| issn | 0272-6386 1523-6838 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71224736 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | anemia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences dialysis Dialysis Outcomes Quality Initiative (DOQI) Emergency and intensive care: renal failure. Dialysis management Evidence-Based Medicine Foundations Guidelines Humans Intensive care medicine Kidney Failure, Chronic - therapy Medical sciences meta-analysis Meta-Analysis as Topic Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Outcome Assessment (Health Care) Peritoneal Dialysis Practice Guidelines as Topic Renal Dialysis Renal failure structured review United States vascular access |
| title | Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A29%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methods%20used%20to%20evaluate%20the%20quality%20of%20evidence%20underlying%20the%20National%20Kidney%20Foundation-dialysis%20outcomes%20quality%20initiative%20clinical%20practice%20guidelines:%20Description,%20findings,%20and%20implications&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Steinberg,%20Earl%20P.&rft.date=2000-07-01&rft.volume=36&rft.issue=1&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/ajkd.2000.8233&rft_dat=%3Cproquest_cross%3E71224736%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71224736&rft_id=info:pmid/10873866&rft_els_id=S0272638600701570&rfr_iscdi=true |